tiprankstipranks
Advertisement
Advertisement

GH Stock Latest News

Mega-Cap Concentration Has Hidden Active Growth’s Best Story: Inside the F/m Emerald Special Situations ETF (SPIT) and a 1st-Percentile Morningstar Track Record
Market NewsMega-Cap Concentration Has Hidden Active Growth’s Best Story: Inside the F/m Emerald Special Situations ETF (SPIT) and a 1st-Percentile Morningstar Track Record
2d ago
EE
GH
Guardant Health initiated with an Outperform at RBC Capital
PremiumThe Fly
Guardant Health initiated with an Outperform at RBC Capital
3d ago
GH
Guardant Health announces U.S. FDA approved Guardant360 CDx
PremiumThe Fly
Guardant Health announces U.S. FDA approved Guardant360 CDx
3d ago
GH
Guardant Health management to meet with Piper Sandler
PremiumThe Fly
Guardant Health management to meet with Piper Sandler
4d ago
GH
Guardant Health price target raised to $175 from $135 at Mizuho
PremiumThe Fly
Guardant Health price target raised to $175 from $135 at Mizuho
6d ago
GH
Tesla upgraded, Lululemon downgraded: Wall Street’s top analyst calls
PremiumThe FlyTesla upgraded, Lululemon downgraded: Wall Street’s top analyst calls
9d ago
BZ
GH
Guardant Health initiated with a Buy at Goldman Sachs
Premium
The Fly
Guardant Health initiated with a Buy at Goldman Sachs
9d ago
GH
Guardant Health upgraded to Outperform from In Line at Evercore ISI
Premium
The Fly
Guardant Health upgraded to Outperform from In Line at Evercore ISI
12d ago
GH
Guardant Health assumed with an Outperform at Wolfe Research
PremiumThe Fly
Guardant Health assumed with an Outperform at Wolfe Research
13d ago
GH
Guardant Health to present 38 abstracts at ASCO 2026 meeting
PremiumThe Fly
Guardant Health to present 38 abstracts at ASCO 2026 meeting
17d ago
GH
PFE
Guardant Health: ACS Shield Endorsement and Camizestrant FDA Tailwind Prompt Price Target Increase to $130 and Reinforce Buy Rating
PremiumRatings
Guardant Health: ACS Shield Endorsement and Camizestrant FDA Tailwind Prompt Price Target Increase to $130 and Reinforce Buy Rating
18d ago
GH
Stifel Reiterates Buy on Guardant Health as ACS Guideline Inclusion of Shield Test Expands Market Opportunity
PremiumRatings
Stifel Reiterates Buy on Guardant Health as ACS Guideline Inclusion of Shield Test Expands Market Opportunity
18d ago
GH
Guardant Health management to meet with Craig-Hallum
PremiumThe FlyGuardant Health management to meet with Craig-Hallum
18d ago
GH
Guardant Health price target raised to $160 from $155 at BTIG
Premium
The Fly
Guardant Health price target raised to $160 from $155 at BTIG
18d ago
GH
ACS recommends Guardant Health’s Shield blood test in screening guidelines
Premium
The Fly
ACS recommends Guardant Health’s Shield blood test in screening guidelines
18d ago
GH
Guardant Health management to meet with Craig-Hallum
PremiumThe Fly
Guardant Health management to meet with Craig-Hallum
19d ago
GH
Guardant Health price target raised to $155 from $145 at BTIG
PremiumThe Fly
Guardant Health price target raised to $155 from $145 at BTIG
19d ago
GH
Guardant Health announces U.S. FDA approved Guardant360 Liquid CDx
PremiumThe Fly
Guardant Health announces U.S. FDA approved Guardant360 Liquid CDx
25d ago
GH
Guardant Health price target raised to $135 from $130 at Piper Sandler
PremiumThe Fly
Guardant Health price target raised to $135 from $130 at Piper Sandler
1M ago
GH
Guardant Health Earnings Call Highlights Breakout Growth
PremiumCompany AnnouncementsGuardant Health Earnings Call Highlights Breakout Growth
1M ago
GH
Guardant Health price target raised to $95 from $90 at Evercore ISI
Premium
The Fly
Guardant Health price target raised to $95 from $90 at Evercore ISI
1M ago
GH
Guardant Health price target raised to $129 from $120 at Baird
Premium
The Fly
Guardant Health price target raised to $129 from $120 at Baird
1M ago
GH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >